Treatment of lung cancer cells with cycloartocarpin at non-toxic concentrations (0–20 μM) significantly diminished the expression levels of EMT markers, such as vimentin, N-cadherin, and Slug (Figure 4), demonstrating the effect of cycloartocarpin in terms of its inhibition of EMT. Here, SNAI2 is linked to lung cancer.